Curaleaf Holdings (CURLF) Asset Writedowns and Impairment (2020 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Asset Writedowns and Impairment of $12.4 million in Q4 2025, up 1563.92% quarter-over-quarter from -$848000.0 in Q3 2025, and up 1199.56% on a YoY basis from $955248.5 in Q4 2024.
Curaleaf Holdings (CURLF) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Curaleaf Holdings' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $12.4 million for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 1199.56% year-over-year to $12.4 million; the TTM figure through Dec 2025 stood at $6.7 million (down 82.79% YoY), while the FY2025 annual figure was $9.1 million, up 2093.24% from the prior year.
- Asset Writedowns and Impairment was $12.4 million for Q4 2025 at Curaleaf Holdings, up from -$848000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $65.7 million in Q4 2023 to a low of -$144.5 million in Q4 2022.
- Historically, Asset Writedowns and Impairment has averaged -$9.4 million across 5 years, with a median of -$988500.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment sank 1670.23% in 2022, then surged 1199.56% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $9.2 million in 2021, then tumbled by 1670.23% to -$144.5 million in 2022, then surged by 145.5% to $65.7 million in 2023, then tumbled by 101.72% to -$1.1 million in 2024, then soared by 1199.56% to $12.4 million in 2025.
- The last three Asset Writedowns and Impairment figures came in at $12.4 million (Q4 2025), -$848000.0 (Q3 2025), and -$3.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.41 Mn |
| Dec 31, 2025 | 12.41 Mn |
| Sep 30, 2025 | -848,000.00 |
| Sep 30, 2025 | -848,000.00 |
| Mar 31, 2025 | -3.70 Mn |
| Mar 31, 2025 | -3.70 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | -642,000.00 |
| Sep 30, 2024 | -642,000.00 |
| Dec 31, 2023 | 65.73 Mn |
| Dec 31, 2023 | 65.73 Mn |
| Sep 30, 2023 | -24.79 Mn |
| Sep 30, 2023 | -24.79 Mn |
| Dec 31, 2022 | -144.46 Mn |
| Dec 31, 2022 | -144.46 Mn |
| Dec 31, 2021 | 9.20 Mn |
| Dec 31, 2021 | 9.20 Mn |
| Sep 30, 2021 | -5.67 Mn |
| Sep 30, 2021 | -5.67 Mn |